Kimberly Greene joins the Aspira Women’s Health team as Vice President, Strategic Partnerships. She is responsible for spearheading strategic academic, national account, and B2B partnerships. Kimberly also leads the commercial launch of the NEW Aspira Synergy Technology Transfer platform, a disruptive technology solution to empower health systems, academic institutions, national accounts, physician groups, and regional labs to accelerate the ability to bring genetic testing and advanced ovarian cancer risk assessment tools in house. She challenges the status quo and traditional means of doing business and research.
Prior to joining the team, Kimberly brings valuable experience backed by a recognized winning track record across field sales, strategic account leadership, and new business development roles at a Fortune 30 company to a multinational corporation to start-up businesses with a focus on domestic as well as international markets. In Kimberly’s prior role with Philips Healthcare, she served as Vice President, Enterprise Operational Informatics. She contributed to expanding a new business niche for the company and spearheaded AI/analytics/IT focused solutions utilizing various sales channels. Kimberly also spent a portion of her career in field sales leadership and research relationship roles across imaging, interventional, oncology, and cardiology service lines at GE Healthcare and IBA Proton Therapy. She started her GE career working with the Harvard medical community in Boston, MA and completed a highly-competitive and respected 18-month Corporate GE Technical Sales Leadership program.
Kimberly earned a B.S. Degree in Mechanical Engineering and a Technical Communications Certificate from the University of Wisconsin-Madison and enrolled in a documentary film CE program at New York University. She volunteers for community service organizations and is an advisor to philanthropic and corporate boards.
Kimberly is thrilled to join the Aspira Women’s Health team. Her personal mission and passion is to collectively build a legacy to globally transform women’s health.